ClinicalTrials.Veeva

Menu

Magnetomotoric Ultrasound (MMUS) in Rectal Cancer (MAMORECT)

R

Region Skane

Status

Enrolling

Conditions

Rectal Cancer

Treatments

Diagnostic Test: Magnetomotoric ultrasound

Study type

Interventional

Funder types

Other

Identifiers

NCT05052086
MAMORECT

Details and patient eligibility

About

Magnetomotoric ultrasound, combines conventional ultrasound with a time-varying magnetic field. The aim is to improve diagnosis of mesolectal lymph nodes.

Full description

Magnetomotoric ultrasound, combines conventional ultrasound with a time-varying magnetic field. Nanoparticles are injected close to the rectal cancer and migrate to adjacent lymph nodes.The time-varying magnetic field will influence the nano particles in the lymph node enhancing diagnosis of affected lymph nodes. The aim is to improve diagnosis of mesolectal lymph nodes and compare the results of magnetomotoric ultrasound with MRI and final histopathology.

Enrollment

60 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Rectal cancer
  • Scheduled for total mesorectal surgery
  • Informed consent

Exclusion criteria

  • Not able to give informed consent
  • Synchronus colorectal cancer

Trial design

Primary purpose

Diagnostic

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

60 participants in 1 patient group

Magnetomotoric ultrasound
Experimental group
Description:
Magnetomotoric ultrasound in addition to MRI.
Treatment:
Diagnostic Test: Magnetomotoric ultrasound

Trial contacts and locations

1

Loading...

Central trial contact

Carl-Fredrik Rönnow, MD, PhD; Henrik Thorlacius, Professor

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems